Argenx
ARGX
#540
Rank
โ‚ฌ31.77 B
Marketcap
520,35ย โ‚ฌ
Share price
-2.18%
Change (1 day)
46.95%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: โ‚ฌ31.77 Billion

As of April 2025 Argenx has a market cap of โ‚ฌ31.77 Billion. This makes Argenx the world's 540th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ31.77 B-11.72%
2024โ‚ฌ35.98 B76.3%
2023โ‚ฌ20.41 B4.48%
2022โ‚ฌ19.53 B20.32%
2021โ‚ฌ16.23 B42.44%
2020โ‚ฌ11.39 B85.66%
2019โ‚ฌ6.14 B100.34%
2018โ‚ฌ3.06 B83.42%
2017โ‚ฌ1.67 B
2014โ‚ฌ0.11 B

End of Day market cap according to different sources

On Apr 15th, 2025 the market cap of Argenx was reported to be:

โ‚ฌ32.44 Billion
by Nasdaq info icon info icon
โ‚ฌ32.44 Billion
by CompaniesMarketCap info icon info icon
โ‚ฌ32.44 Billion
by Yahoo Finance info icon info icon